Matches in Wikidata for { <http://www.wikidata.org/entity/Q90934006> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q90934006 description "article scientifique publié en 2019" @default.
- Q90934006 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q90934006 description "im Januar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90934006 description "scientific article published on 08 January 2019" @default.
- Q90934006 description "wetenschappelijk artikel" @default.
- Q90934006 description "наукова стаття, опублікована 8 січня 2019" @default.
- Q90934006 name "Intravitreal bevacizumab treatment for neovascular age-related macular degeneration and thromboembolic events" @default.
- Q90934006 name "Intravitreal bevacizumab treatment for neovascular age-related macular degeneration and thromboembolic events" @default.
- Q90934006 type Item @default.
- Q90934006 label "Intravitreal bevacizumab treatment for neovascular age-related macular degeneration and thromboembolic events" @default.
- Q90934006 label "Intravitreal bevacizumab treatment for neovascular age-related macular degeneration and thromboembolic events" @default.
- Q90934006 prefLabel "Intravitreal bevacizumab treatment for neovascular age-related macular degeneration and thromboembolic events" @default.
- Q90934006 prefLabel "Intravitreal bevacizumab treatment for neovascular age-related macular degeneration and thromboembolic events" @default.
- Q90934006 P1433 Q90934006-6976BE41-7A02-4C37-84CA-ED314BA443B0 @default.
- Q90934006 P1476 Q90934006-DA2C8CE1-D7B9-4422-9E27-62AD6F69CCE7 @default.
- Q90934006 P2093 Q90934006-571933CC-31A6-4985-9163-06387CBEFF5F @default.
- Q90934006 P2093 Q90934006-6E415247-1F75-4CAA-9D57-6DB7C5550BF1 @default.
- Q90934006 P2093 Q90934006-9040C2DE-177C-472B-A71B-EEC382F22E82 @default.
- Q90934006 P2093 Q90934006-A4B30FCB-2B9D-4ED9-96C5-71A8484FC918 @default.
- Q90934006 P304 Q90934006-190CF31F-1A68-4007-BEC8-645577689BEC @default.
- Q90934006 P31 Q90934006-366D5BC8-5A56-4F57-A96A-544A1869C9C2 @default.
- Q90934006 P356 Q90934006-CC3CAF45-2C54-421A-B6E0-4531F5DECBE0 @default.
- Q90934006 P433 Q90934006-786C823C-C385-4726-8392-6244294D1A14 @default.
- Q90934006 P478 Q90934006-CA164A5B-1DE3-4C58-B272-D8562410C195 @default.
- Q90934006 P50 Q90934006-E499504D-50B1-44AD-A066-987744BD69FC @default.
- Q90934006 P577 Q90934006-0ADD512B-04D8-4592-A324-34774CA7B4C0 @default.
- Q90934006 P698 Q90934006-BD9895EE-EB40-4CA9-8389-AA8579B1309D @default.
- Q90934006 P921 Q90934006-4DDBA300-8700-4B41-A9C3-6197D42A76CE @default.
- Q90934006 P921 Q90934006-DA12D270-AFDC-413A-BEC5-24B0852F3CA4 @default.
- Q90934006 P356 1120672118823128 @default.
- Q90934006 P698 30618282 @default.
- Q90934006 P1433 Q15755023 @default.
- Q90934006 P1476 "Intravitreal bevacizumab treatment for neovascular age-related macular degeneration and thromboembolic events" @default.
- Q90934006 P2093 "Jaime Levy" @default.
- Q90934006 P2093 "Orly Weinstein" @default.
- Q90934006 P2093 "Tova Lifshitz" @default.
- Q90934006 P2093 "Victor Novack" @default.
- Q90934006 P304 "66-71" @default.
- Q90934006 P31 Q13442814 @default.
- Q90934006 P356 "10.1177/1120672118823128" @default.
- Q90934006 P433 "1" @default.
- Q90934006 P478 "30" @default.
- Q90934006 P50 Q60300198 @default.
- Q90934006 P577 "2019-01-08T00:00:00Z" @default.
- Q90934006 P698 "30618282" @default.
- Q90934006 P921 Q27429789 @default.
- Q90934006 P921 Q413299 @default.